1. Home
  2. JCTC vs GLYC Comparison

JCTC vs GLYC Comparison

Compare JCTC & GLYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCTC
  • GLYC
  • Stock Information
  • Founded
  • JCTC 1953
  • GLYC 2003
  • Country
  • JCTC United States
  • GLYC United States
  • Employees
  • JCTC N/A
  • GLYC N/A
  • Industry
  • JCTC
  • GLYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCTC
  • GLYC Health Care
  • Exchange
  • JCTC NYSE
  • GLYC Nasdaq
  • Market Cap
  • JCTC 14.7M
  • GLYC 15.9M
  • IPO Year
  • JCTC 1996
  • GLYC 2014
  • Fundamental
  • Price
  • JCTC $4.20
  • GLYC $0.18
  • Analyst Decision
  • JCTC
  • GLYC Hold
  • Analyst Count
  • JCTC 0
  • GLYC 3
  • Target Price
  • JCTC N/A
  • GLYC N/A
  • AVG Volume (30 Days)
  • JCTC 7.3K
  • GLYC 263.1K
  • Earning Date
  • JCTC 04-14-2025
  • GLYC 05-08-2025
  • Dividend Yield
  • JCTC N/A
  • GLYC N/A
  • EPS Growth
  • JCTC N/A
  • GLYC N/A
  • EPS
  • JCTC N/A
  • GLYC N/A
  • Revenue
  • JCTC $46,606,336.00
  • GLYC N/A
  • Revenue This Year
  • JCTC N/A
  • GLYC N/A
  • Revenue Next Year
  • JCTC N/A
  • GLYC N/A
  • P/E Ratio
  • JCTC N/A
  • GLYC N/A
  • Revenue Growth
  • JCTC N/A
  • GLYC N/A
  • 52 Week Low
  • JCTC $3.86
  • GLYC $0.14
  • 52 Week High
  • JCTC $5.69
  • GLYC $2.81
  • Technical
  • Relative Strength Index (RSI)
  • JCTC N/A
  • GLYC 26.25
  • Support Level
  • JCTC N/A
  • GLYC $0.24
  • Resistance Level
  • JCTC N/A
  • GLYC $0.22
  • Average True Range (ATR)
  • JCTC 0.00
  • GLYC 0.02
  • MACD
  • JCTC 0.00
  • GLYC -0.01
  • Stochastic Oscillator
  • JCTC 0.00
  • GLYC 4.49

About JCTC JEWETT-CAMERON TRADING CO

Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.

About GLYC GlycoMimetics Inc.

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

Share on Social Networks: